D. E. Shaw & Co., Inc. Uni Qure N.V. Call Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $1.28 Million - $1.85 Million	-43,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $787,200 - $1.54 Million	20,000 Added 83.68%	43,900 $1.73 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $1.26 Million - $1.96 Million	23,900 New	23,900 $1.87 Million

154

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $333M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.